# Commission Decision of 7 May 2002 on common technical specifications for in vitro-diagnostic medical devices (notified under document number C(2002) 1344) (Text with EEA relevance) (2002/364/EC), Division 3.5.5

Extent: E+W+S+N.I.

Devices shall be evaluated to establish the effect of potential interfering substances, as part of the performance evaluation. The potential interfering substances to be evaluated will depend to some extent on the composition of the reagent and configuration of the assay. Potential interfering substances shall be identified as part of the risk analysis required by the essential requirements for each new device.

---
Source: https://www.legislation.gov.uk/eudn/2002/364/annex/division/3/division/3.5/division/3.5.5 (the official version)
Page: https://openlegislation.uk/eu-decision-2002-364/annex/division-3/division-3.5/division-3.5.5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.